Literature DB >> 15931602

Malnutrition and nonthyroidal illness syndrome after stroke.

Seiji Hama1, Tamotsu Kitaoka, Masaya Shigenobu, Atsuko Watanabe, Ikuo Imura, Hidetaka Seno, Atsushi Tominaga, Kazunori Arita, Kaoru Kurisu.   

Abstract

In the present study, nonthyroidal illness syndrome (NTIS), which is characterized by reduction of serum triiodothyronine (T3) without elevation of thyroid-stimulating hormone (TSH), was induced by protein-energy malnutrition (PCM). Protein-energy malnutrition is a common condition and is associated with worse clinical outcome in stroke patients admitted to a rehabilitation service. However, little is known about NTIS in stroke patients. Therefore, we studied the effects of PCM and NTIS on functional dependence in 51 stroke patients. We examined thyroid function by measuring serum free T3 (free T3), free thyroxine (free T4), and TSH. We estimated whether patients had mild NTIS (reduction of only free T3) or serious NTIS (reduction of both free T3 and free T4), examined PCM by measuring serum albumin, calculated body mass index (BMI) from weight and height on admission, and examined disability by obtaining the functional independence measurement (FIM). The 51 patients were divided into 2 groups according to FIM score on admission (low and high). The low-FIM group was divided into 2 subgroups according to the change in FIM score during hospitalization (improved or non-improved). Hypoalbuminemia was observed in 57% of patients, underweight in 22%, and mild NTIS in 82%; serious NTIS was not observed in any patients. Albumin and BMI were significantly higher in the high-FIM group than in the low-FIM group. Serum albumin concentration and BMI significantly positively correlated with free T3. Free T3 (but not albumin or BMI) was significantly higher in the improved subgroup than in the non-improved subgroup. Nonthyroidal illness syndrome after stroke was common and was provoked by PCM, which occurred in a high proportion of functionally dependent patients. It appears that, once stroke patients develop NTIS, it is difficult to achieve functional improvement. Therefore, during the recovery period after stroke, it is important to determine whether NTIS is present and ensure proper intensive rehabilitation and nutritional management.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15931602     DOI: 10.1016/j.metabol.2004.11.016

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  6 in total

1.  Clinical analysis on alteration of thyroid hormones in the serum of patients with acute ischemic stroke.

Authors:  Yonghua Zhang; Michael A Meyer
Journal:  Stroke Res Treat       Date:  2010-08-09

Review 2.  Thyroid Hormones in the Brain and Their Impact in Recovery Mechanisms After Stroke.

Authors:  Daniela Talhada; Cecília Reis Alves Santos; Isabel Gonçalves; Karsten Ruscher
Journal:  Front Neurol       Date:  2019-10-18       Impact factor: 4.003

3.  Impaired Nutritional Condition After Stroke From the Hyperacute to the Chronic Phase: A Systematic Review and Meta-Analysis.

Authors:  Viviënne Huppertz; Sonia Guida; Anne Holdoway; Stefan Strilciuc; Laura Baijens; Jos M G A Schols; Ardy van Helvoort; Mirian Lansink; Dafin F Muresanu
Journal:  Front Neurol       Date:  2022-02-01       Impact factor: 4.003

4.  Role of enteral nutrition in nonthyroidal illness syndrome: a retrospective observational study.

Authors:  Ranran Li; Jianan Ren; Qin Wu; Gefei Wang; Xiuwen Wu; Jun Chen; Guanwei Li; Zhiwu Hong; Huajian Ren; Yunzhao Zhao; Jieshou Li
Journal:  BMC Endocr Disord       Date:  2015-11-04       Impact factor: 2.763

5.  Correlation analysis of serum thyroid stimulating hormone with acute cerebrovascular disease.

Authors:  Jian Zhu; Ming Chen; Nan Li; Shaoling Yang; Lu Xu; Yanru Wang; Hong Li
Journal:  Eur J Med Res       Date:  2019-10-24       Impact factor: 2.175

6.  Investigation of the Effect of Nutritional Supplementation with Whey Protein and Vitamin D on Muscle Mass and Muscle Quality in Subacute Post-Stroke Rehabilitation Patients: A Randomized, Single-Blinded, Placebo-Controlled Trial.

Authors:  Kaoru Honaga; Naoki Mori; Tomonori Akimoto; Masahiro Tsujikawa; Michiyuki Kawakami; Tomoyuki Okamoto; Yasuyuki Sakata; Hirokazu Hamano; Yasuhiro Takeda; Kunitsugu Kondo
Journal:  Nutrients       Date:  2022-02-06       Impact factor: 5.717

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.